Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Clin Cancer Res. 2014 Jan 31;20(7):1856–1864. doi: 10.1158/1078-0432.CCR-13-2109

Figure 3. Validation of the Sensitivity of Methylation-Specific PCR for 3 Genes in Two Independent Cohorts.

Figure 3

Methylation of at least one gene-promoter among CDO1, HOXA9, or TAC1 by methylation-specific PCR identifies 94.9% of NSCLC cases in 59-patient United States cohort A and 83.3% of NSCLC cases from the independent 30-patient Japanese cohort B.